SignatureFD’s Bioventus BVS Stock Holding History

SignatureFD’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$623	Buy	+66	New	+$630	﹤0.01%	3327
2025 Q2	–	Sell	-834	Closed	-$7.63K	–	3285
2025 Q1	$7.63K	Sell	834 -450	-35%	-$4.5K	﹤0.01%	2462
2024 Q4	$13.5K	Hold	1,284	–	–	﹤0.01%	2248
2024 Q3	$15.3K	Buy	+1,284	New	+$11.1K	﹤0.01%	2166
2023 Q3	–	Sell	-1,688	Closed	-$4.88K	–	3208
2023 Q2	$4.88K	Buy	1,688 +844	+100%	+$1.62K	﹤0.01%	2528
2023 Q1	$903	Hold	844	–	–	﹤0.01%	3015
2022 Q4	$2.2K	Hold	844	–	–	﹤0.01%	2787
2022 Q3	$6K	Sell	844 -523	-38%	-$4.09K	﹤0.01%	2321
2022 Q2	$9K	Buy	1,367 +221	+19%	+$2.25K	﹤0.01%	2147
2022 Q1	$16K	Sell	1,146 -26	-2%	-$348	﹤0.01%	1948
2021 Q4	$17K	Buy	1,172 +1,115	+1,956%	+$15.8K	﹤0.01%	1848
2021 Q3	$1K	Buy	+57	New	+$877	﹤0.01%	2784

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SignatureFD's BVS Position: Q2 2026 in Review

SignatureFD opened a new position in Bioventus (BVS) in Q2 2026: 66 shares worth $623. The stake represents ﹤0.01% of the portfolio and ranks #3327 among its holdings. This is a return to the name: SignatureFD previously reported a position in BVS as recently as Q1 2025.

SignatureFD first reported a position in BVS in Q3 2021 and has held it in 12 quarters since. The position peaked at $17K in Q4 2021. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

SignatureFD held 66 shares of Bioventus worth $623 as of Q2 2026.
Bioventus was a new SignatureFD position in Q2 2026.
Bioventus made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3327 holding.
SignatureFD first reported a position in Bioventus in Q3 2021 and has held it in 12 quarters since.
SignatureFD's Bioventus position peaked at $17K in Q4 2021.
156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.